Category: Novos
-
US FDA flags dosing risks from compounded versions of Novo’s weight-loss drug By Reuters
•
(Reuters) – The U.S. Food and Drug Administration on Friday warned patients and doctors about dosing errors linked to combination versions of Novo Nordisk’s weight-loss and diabetes drugs. The health regulator said it had received reports of adverse events, some requiring hospitalization, that may have been linked to overdoses caused…
-
Novo’s Wegovy induces higher weight loss in women than men with same heart condition, study shows By Reuters
•
Written by Jakob Gronholt Pedersen and Bhanvi Satya COPENHAGEN (Reuters) – An analysis of data from a study published in a medical journal showed that Novo Nordisk Inc’s (NYSE) popular obesity drug WiGovi helped women with common heart diseases lose more weight than men with the same condition. The trials…